Email This Article

Headlines & Perspectives
Drug Approvals Lift Tercica, Novartis
By Elizabeth Trotta
08/31/07 - 12:21 PM EDT
Separate nods from regulatory agencies in the U.S. and Europe boost these names.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,372.80 1,106.46 2,192.48 33.31
Oil *
78.58
UP
102.33
UP
12.98
UP
24.60
DOWN
0.98
10 Yr
3.33%
SPDR Gold
111.79
+1.00%
+1.19%
+1.13%
-2.86%
Data delayed 20 minutes

Brokerage Partners